Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike A Scott

Showing results (21-30 of 29) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|January 26, 2019
Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasmsAnna L Paterson, Hesham El-Daly, Livia Raso-Barnett, et al.
Lancet (London, England)|March 23, 2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersE Joanna Baxter, Linda M Scott, Peter J Campbell, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Blood|May 31, 2002
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.
Genome Research|September 12, 2006
Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sitesGeorge A Follows, Pawan Dhami, Berthold Göttgens, et al.
The New England Journal of Medicine|February 3, 2007
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosisLinda M Scott, Wei Tong, Ross L Levine, et al.
Cell Reports|March 4, 2015
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesisThomas McKerrell, Naomi Park, Thaidy Moreno, et al.
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
Lancet (London, England)|December 6, 2005
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyPeter J Campbell, Linda M Scott, Georgina Buck, et al.
Pageof 3

Showing results (21-30 of 29) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 29 results.
British Journal of Haematology|January 26, 2019
Contribution of immunoglobulin lambda light chain gene rearrangement analysis in the diagnosis of B-cell neoplasmsAnna L Paterson, Hesham El-Daly, Livia Raso-Barnett, et al.
Lancet (London, England)|March 23, 2005
Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disordersE Joanna Baxter, Linda M Scott, Peter J Campbell, et al.
British Journal of Haematology|May 29, 2010
AT9283, a potent inhibitor of the Aurora kinases and Jak2, has therapeutic potential in myeloproliferative disordersMark A Dawson, Jayne E Curry, Kelly Barber, et al.
Blood|May 31, 2002
Derivative chromosome 9 deletions in chronic myeloid leukemia: poor prognosis is not associated with loss of ABL-BCR expression, elevated BCR-ABL levels, or karyotypic instabilityBrian J P Huntly, Anthony J Bench, Eric Delabesse, et al.
Genome Research|September 12, 2006
Identifying gene regulatory elements by genomic microarray mapping of DNaseI hypersensitive sitesGeorge A Follows, Pawan Dhami, Berthold Göttgens, et al.
The New England Journal of Medicine|February 3, 2007
JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosisLinda M Scott, Wei Tong, Ross L Levine, et al.
Cell Reports|March 4, 2015
Leukemia-associated somatic mutations drive distinct patterns of age-related clonal hemopoiesisThomas McKerrell, Naomi Park, Thaidy Moreno, et al.
Blood|April 14, 2005
Conservation of unique cell-surface CD antigen mosaics in HIV-1-infected individualsAdrian Woolfson, Justin Stebbing, Brian D M Tom, et al.
Lancet (London, England)|December 6, 2005
Definition of subtypes of essential thrombocythaemia and relation to polycythaemia vera based on JAK2 V617F mutation status: a prospective studyPeter J Campbell, Linda M Scott, Georgina Buck, et al.
Pageof 3